Multi-biomarker risk stratification of N-terminal pro-B-type natriuretic peptide, high-sensitivity C-reactive protein, and cardiac troponin T and I in end-stage renal disease for all-cause death

Clinical Chemistry

Volumn 50, Issue 12, 2004, Pages 2279-2285

  Apple, Fred S ^a,c   Murakami, Mary Ann M ^a   Pearce, Lesly A ^b   Herzog, Charles A ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b Biostatistical Consulting   (United States)

^c HENNEPIN COUNTY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; BRAIN NATRIURETIC PEPTIDE; C REACTIVE PROTEIN; TROPONIN I; TROPONIN T;

ARTICLE; CARDIOVASCULAR RISK; CAUSE OF DEATH; DIAGNOSTIC VALUE; DISEASE MARKER; KIDNEY FAILURE; PROGNOSIS; PROTEIN BLOOD LEVEL; RISK ASSESSMENT; RISK FACTOR;

ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; HEART DISEASES; HUMANS; KIDNEY FAILURE, CHRONIC; MIDDLE AGED; MYOCARDIUM; NATRIURETIC PEPTIDE, BRAIN; NERVE TISSUE PROTEINS; PEPTIDE FRAGMENTS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROTEIN PRECURSORS; REFERENCE VALUES; RISK; ROC CURVE; SURVIVAL ANALYSIS; TROPONIN I; TROPONIN T;

EID: 9244250381     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1373/clinchem.2004.035741     Document Type: Article

References (34)

1. US Renal Data System: USRDS 1999 annual data report. Bethesda, MD: NIH, National Institute of Diabetes and Digestive and Kidney Disease, 1999:D1-37.
2. US Renal Data System: USRDS 1999 annual data report. Bethesda, MD: NIH, National Institute of Diabetes and Digestive and Kidney Disease, 1999:89-100.
3. Herzog CA, Ma JZ, Collings AJ. Poor long-term survival after acute myocardial infarction among patients on long-term dialysis. N Engl J Med 1998;339:779-805.
4. Bleyer AJ, Russell GB, Satko SG. Sudden and cardiac death rates in hemodialysis patients. Kidney Int 1999;55:1553-9.
5. Clerico A, Caprioli R, Del Ry S, Giannessi D. Clinical relevance of cardiac natriuretic peptides measured by means of competitive and non-competitive immunoassay methods in patients with renal failure on chronic hemodialysis. J Endocrinol Invest 2001;24:24-30.
6. Cataliotti A, Malatino LS, Jougasaki M, Zoccali C, Castellino P, Giacone G, et al. Circulating natriuretic peptide concentrations in patients with end-stage renal disease: role of brain natriuretic peptide as a biomarker for ventricular remodeling. Mayo Clin Proc 2001;76:1111-9.
7. Arici M, Walls J. End-stage renal disease, atherosclerosis, and cardiovascular mortality: is C-reactive protein the missing link. Kidney Int 2001;59:407-14.
8. Apple FS, Murakami MM, Pearce LA, Herzog CA. Predictive value of cardiac troponin I and T for subsequent death in end-stage renal disease. Circulation 2002;106:2941-5.
9. Ridker PM. Clinical application of C-reactive protein for cardiovascular disease detection and prevention. Circulation 2003;107:363-9.
10. Yeun JY, Levine RA, Mantadilok V, Kaysen G. C-Reactive protein predicts all-cause death and cardiovascular mortality in hemodialysis patients. Am J Kidney Dis 2000;35:469-76.
11. Zimmerman J, Herrlinger S, Pruz A, Wanner C, Metzger T. Inflammation enhances cardiovascular risk and mortality in hemodialysis patients. Kidney Int 1999;55:648-58.
12. Stenvinkel P, Wanner C, Metzger T, Heimburger O, Mallamaci F, Tripepi G, et al. Inflammation and outcome in end-stage renal failure: does female gender constitute a survival advantage? Kidney Int 2002;62:1791-8.
13. Mallamaci F, Zoccali C, Parlongo S, Tripepi G, Benedetto FA, Cutrupi S, et al. Troponin is related to left ventricular mass and predicts all-cause and cardiovascular mortality in hemodialysis patients. Am J Kidney Dis 2002;40:68-75.
14. Jaffe AS, Ravkilde J, Roberts R, Naslund U, Apple FS, Galvani M, et al. It's time for a change to a troponin standard. Circulation 2000;102:1216-20.
15. Braunwald E, Antman EM, Beasley JW, Califf RM, Cheitlin MD, Hochman JS, et al. ACC/AHA guidelines for the management of patients with unstable angina and non-ST-segmeht elevation myocardial infarction. J Am Coll Cardiol 2000;36:970-1062.
16. Joint European Society of Cardiology/American College of Cardiology Committee. Myocardial infarction defined-a consensus document of the joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol 2000;36:959-69.
17. Heidenreich PA, Alloggiamento T, Melsop K, McDonald KM, Go AG, Hlatky MA. The prognostic value of troponin in patients with non-ST-elevation acute coronary syndromes: a meta-analysis. J Am Coll Cardiol 2001;38:478-85.
18. Aviles RJ, Askari AT, Lindahl B, Wallentin L, Jia G, Ohman EM, et al. Troponin T levels in patients with acute coronary syndromes, with or without renal dysfunction. N Engl J Med 2002;346:2047-52.
19. Ottani F, Galvani M, Nicolini FA, Ferrini D, Pozzati A, Di Pasquale G, et al. Elevated cardiac troponin levels predict the risk of adverse outcome in patients with acute coronary syndromes. Am Heart J 2000;140:917-27.
20. Morrow DA, Cannon CP, Rifai N, Frey MJ, Vicari R, Lakkis N, et al. Ability of minor elevations of troponins I and T to predict benefit from an early invasive strategy in patients with unstable angina and non-ST elevation myocardial infarction. JAMA 2001;286:2405-12.
21. Bertrand ME, Simons ML, Fox KAA, Wallentin LC, Hamm CW, McFadden E, et al. Management of acute coronary syndromes: acute coronary syndromes without persistent ST-segment elevation. Eur Heart J 2000;21:1406-32.
22. Ishizaka Y, Yamamoto Y, Tanaka M, Kato F, Ishizaka Y, Kato J, et al. Molecular forms of human brain natriuretic peptide (BNP) in plasma of patients on hemodialysis (HD). Clin Nephrol 1995;43:237-42.
23. Sabatine MS, Morrow DA, de Lemos JA, Gibson CM, Murphy SA, Rifai N, et al. Multimarker approach to risk stratification in non-ST-elevation acute coronary syndromes: simultaneous assessment of troponin I, C-reactive protein, and B-type natriuretic peptide. Circulation 2002;105:1760-3.
24. McCullough PA, Sandberg KR. B-Type natriuretic peptides and renal disease. Heart Fail Rev 2003;8:355-8.
25. Morrow DA, Rifai N, Antman EM, Weiner DL, McCabe CH, Cannon CP, et al. C-Reactive protein is a potent predictor of mortality independently of and in combination with troponin T in acute coronary syndromes: a TIMI II substudy. J Am Coll Cardiol 1998;31:1460-5.
26. Karl J, Borgya A, Gallusser A, Huber E, Kruger K, Rollinger W, et al. Development of a novel, N-terminal-proBNP (NT-proBNP) assay with a low detection limit. Scand J Clin Lab Invest 1999;59(Suppl 230):177-81.
27. Eda S. Development of a new microparticle-enhanced turbidimetric assay for C-reactive protein with superior features in sensitivity and dynamic range. J Clin Lab Anal 1998;12:137-44.
28. Apple FS, Wu AHB, Jaffe AS. European Society of Cardiology and American College of Cardiology guidelines for redefinition of myocardial infarction: how to use existing assays clinically and for clinical trials. Am Heart J 2002;144:981-6.
29. deFilippi CR, Tocci M, Parmar RJ, Rosanio S, Abreo G, Potter MA, et al. Cardiac troponin T in chest pain unit patients without ischemic electrocardiographic changes: angiographic correlates and long-term clinical outcomes. J Am Coll Cardiol 2000;35:1827-34.
30. Panteghini M, Cuccia C, Pagani F, Turla C, Bonetti G, Bonini E. Coronary angiographic findings in patients with clinical unstable angina according to cardiac troponin I and T concentrations in serum. Arch Pathol Lab Med 2002;126:448-51.
31. deFilippi C, Wasserman S, Rosanio S, Tiblier E, Sperger H, Tocchi M, et al. Cardiac troponin T and C-reactive protein for predicting prognosis, coronary atherosclerosis, and cardiomyopathy in patients undergoing long-term hemodialysis. JAMA 2003;290:353-9.
32. Jessup M, Brozena S. Heart failure. N Engl J Med 2003;348:2007-18.
33. Jernberg T, Lindahl B, Siegbahn A, Andren B, Frostfeldt G, Lagerqvist B, et al. N-Terminal pro-brain natriuretic peptide in relation to inflammation, myocardial necrosis, and the effect of an invasive strategy in unstable coronary artery disease. J Am Coll Cardiol 2003;42:1909-16.
34. Venge P, Lagerqvist B, Diderholm E, Lindahl B, Wallentin L. Clinical performance of three cardiac troponin assays in patient with unstable coronary artery disease (a FRISC II substudy). Am J Cardiol 2002;89:1035-41.